Key result
Dexmedetomidine significantly reduced time of extubation, pain scores, ICU and hospital length of stay, and intra-operative fentanyl requirements compared to saline in pediatric cardiac surgery.
Why the study?
Does dexmedetomidine improve recovery profile and reduce ICU length of stay in pediatric patients undergoing elective correction of congenital heart diseases using CPB?
RCT (n=40)
Randomly classified
Does dexmedetomidine improve recovery profile and reduce ICU length of stay in pediatric patients undergoing elective correction of congenital heart diseases using CPB?
Dexmedetomidine as an adjuvant during pediatric cardiac surgery reduces extubation time, analgesic requirements, and ICU/hospital length of stay.
No takes yet. Share an insight, caveat, or question.
Supports dexmedetomidine adjunct use in pediatric cardiac anesthesia; extends RCT evidence for improved recovery after congenital heart repair.
El-Morsy et al. (2014) conducted an RCT in Simple congenital heart diseases (n=40). Dexmedetomidine vs. Saline was evaluated on Recovery profile, ICU length of stay, analgesic needs, and hospital stay. Dexmedetomidine significantly reduced time of extubation, pain scores, ICU and hospital length of stay, and intra-operative fentanyl requirements compared to saline in pediatric cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: